Transfusion Dependent Beta-Thalassaemia
4 clinical trials · Condition
◉ Watch Transfusion Dependent Beta-Thalassaemia
| Record | Firm | Date |
|---|---|---|
| Hematopoietic Stem Cell BCL11A Enhancer Gene Editing for Severe β-Hemoglobinopathies (NCT06647979) | Daniel Bauer | 2025-12-01 |
| A Study to Evaluate the Safety and Efficacy of ET-01 Transplantation in Subjects with Transfusion Dependent Β-Thalassaemia. (NCT05752123) | EdiGene (GuangZhou) Inc. | 2023-02-18 |
| Safety and Efficacy Evaluation of ET-01 Transplantation in Subjects With Transfusion Dependent β-Thalassaemia (NCT04390971) | Institute of Hematology & Blood Diseases Hospital, China | 2023-02-10 |
| A Safety and Efficacy Study Evaluating ET-01 in Subjects with Transfusion Dependent Β-Thalassaemia (NCT04925206) | EdiGene (GuangZhou) Inc. | 2021-08-17 |
Track Transfusion Dependent Beta-Thalassaemia automatically
Every clearance here is in the API, with alerts when new ones post.